OncoHost To Present PROphet® Biomarker Model That Accurately Predicts Clinical Benefit to ICI-Based Treatment
OncoHost has announced that it will give a poster presentation demonstrating the accuracy of its PROphet® biomarker model at the upcoming American Society of Clinical Oncology Annual Meeting, taking place June 2-6, 2023, in Chicago, Illinois.
Form Bio Selected by Google Cloud To Help Organizations Adopt New AI-Powered Life Sciences Solutions
Form Bio announced that it has been selected to help organizations adopt Google Cloud's Multiomics Suite, accelerating the research of life science companies and academic institutions.
Personalis, National Cancer Center Hospital East and Ono Collaborate To Better Predict Immunotherapy Response for Rectal Cancer
Personalis, Inc., National Cancer Center and Ono Pharmaceutical Co., Ltd. have announced they have entered into a collaborative agreement to examine the efficacy and safety of nivolumab, an immune checkpoint inhibitor, for resectable rectal cancer with mismatch repair deficiency.
Thermo Fisher Scientific Introduces New Low-Flow HPLC Columns for Proteomic Research
Thermo Fisher Scientific is providing proteomics and biopharmaceutical research laboratories with a new line of low-flow HPLC columns that improve separation performance and stability of biologically complex samples.
Waters Corporation Introduces RapiZyme Trypsin
Waters Corp announces RapiZyme™ Trypsin, a chemically optimized, recombinant trypsin. This trypsin provides gold-standard performance while cutting lengthy digestion times from over three hours to just 30 minutes.
Exhaled Volatile Organic Compounds as Biomarkers for Liver Disease Detection
Owlstone Medical has announced the publication of a peer-reviewed study that identifies a set of volatile organic compounds that can identify patients with liver disease and separate them based on severity.